Tg Therapeutics (TGTX) Property, Plant & Equipment (Net) Growth (1y) (2012 - 2024)
Tg Therapeutics (TGTX) Property, Plant & Equipment (Net) Growth (1y) (2012 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 58.66% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -10.19% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 2.65% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 24.11% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 12.18% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | -95.71% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Tg Therapeutics | 8.10 Bn | 8.03 Bn | 171.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -72.15% |
| Dec 31, 2023 | -69.06% |
| Sep 30, 2023 | -64.63% |
| Jun 30, 2023 | -53.91% |
| Mar 31, 2023 | -54.94% |
| Dec 31, 2022 | -48.83% |
| Sep 30, 2022 | -37.33% |
| Jun 30, 2022 | -25.13% |
| Mar 31, 2022 | 7.79% |
| Dec 31, 2021 | 24.74% |
| Sep 30, 2021 | 58.73% |
| Jun 30, 2021 | 80.36% |
| Mar 31, 2021 | 52.50% |
| Dec 31, 2020 | 70.57% |
| Sep 30, 2020 | 37.45% |
| Jun 30, 2020 | 39.66% |
| Mar 31, 2020 | 32.78% |
| Dec 31, 2019 | 12.35% |
| Sep 30, 2019 | 2.61% |
| Jun 30, 2019 | -10.57% |